Navigation Links
Virginia Tech engineer receives NSF grant to study Colorado flood effects on antibiotic resistance
Date:1/9/2014

The World Health Organization and the Center for Disease Control has recognized antibiotic resistance "as a critical health challenge of our time," said Amy Pruden, a Virginia Tech environmental engineer who is credited with pioneering the concept of antibiotic resistance genes as environmental pollutants.

Pruden said reducing the spread of antibiotic resistance is a critical measure needed to prolong the effectiveness of currently available antibiotics. This is important since "new drug discovery can no longer keep pace with emerging antibiotic-resistant infections," Pruden said.

Pruden is a 2006 National Science Foundation (NSF) CAREER award recipient as well as a 2007 Presidential Early Career Award in Science and Engineering (PECASE) honoree.

Pruden's unique expertise in characterizing environmental sources and pathways of antibiotic resistance has garnered her as lead of a new NSF RAPID grant to study the recent Colorado flood's effect on antibiotic resistance genes. She will work with Mazddak Arabi of Colorado State University and Diana Aga of the University of Buffalo on the project that will improve the understanding of the role the watershed processes play in disseminating resistance.

For more than 10 years, this research team has monitored the watershed of the South Platte River Basin, southwest of Denver, Colo. "We have already generated a robust data set of antibiotic resistance genes and antibiotics, as well as a unique interdisciplinary watershed-scale approach for characterizing the land-use on their distribution," Pruden explained.

The recent Colorado flooding occurred during the week of Sept. 9, 2013, with flood waters affecting 17 counties over a spread of 200 miles north to south, transporting enormous loads of sediment and transforming the semi-arid landscape of the Front Range of Colorado.

When an antibiotic is consumed, researchers have learned that up to 90 percent passes through a body
'/>"/>

Contact: Lynn Nystrom
tansy@vt.edu
540-231-4371
Virginia Tech
Source:Eurekalert  

Page: 1 2 3

Related biology news :

1. Virginia Techs De Vita receives governments highest of engineering honors to study pelvic disorder
2. Virginia Tech research overturns assumption about mercury in the Arctic
3. Virginia Tech researchers explore natural way to displace harmful germs from household plumbing
4. Widespread but neglected disease a health threat in Africa, Virginia Tech researchers say
5. Biofilms help Salmonella survive hostile conditions, Virginia Tech researchers say
6. Natures phenomena might teach Virginia Tech engineers new tricks
7. Virginia Tech adjunct and colleagues refute a study on racial bias report in NIH awards
8. Virginia Tech expands sports concussion-risk studies to include hockey and baseball
9. Virginia Woolf and Neuropsychiatry
10. Virginia Tech computer scientists develop new way to study molecular networks
11. TESARO and Virginia G. Piper Cancer Center announce first patient in clinical trial of TSR-011
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Virginia Tech engineer receives NSF grant to study Colorado flood effects on antibiotic resistance
(Date:7/8/2015)... Summary Pancreatic cancer is the 12th ... with a mortality rate of 10.9 deaths per 100,000 ... patients has highlighted a significant need for new and ... by the current market. A highly active pancreatic ... molecule types and mechanisms of action, which provides a ...
(Date:7/8/2015)... 2015  Trovagene, Inc. (NASDAQ: TROV ), ... the launch of a study that aims to ... (PCM) technology for predicting response to treatment in ... of the novel immunotherapy agents Yervoy® (ipilumumab), a ... The 50-patient study will be led by researchers ...
(Date:7/7/2015)... Research and Markets ... the "Capacitive Fingerprint Sensors Patent Landscape" ... date, fingerprint sensing technology is the most reliable ... well developed. This patent landscape focuses on fingerprint ... domain of capacitive fingerprint sensors is closely linked ...
Breaking Biology News(10 mins):Frontier Pharma: Pancreatic Cancer - Identifying and Commercializing First-in-Class Innovation 2Frontier Pharma: Pancreatic Cancer - Identifying and Commercializing First-in-Class Innovation 3Trovagene Initiates Study to Monitor Response to Immunotherapy in Melanoma Patients Using its Precision Cancer Monitoring Platform 2Trovagene Initiates Study to Monitor Response to Immunotherapy in Melanoma Patients Using its Precision Cancer Monitoring Platform 3Trovagene Initiates Study to Monitor Response to Immunotherapy in Melanoma Patients Using its Precision Cancer Monitoring Platform 4Worldwide Capacitive Fingerprint Sensors Patent Landscape Market Report 2015-2020 - Main IP Holders include Seiko Epson, AuthenTec, Sony and STMicroelectronics 2
... March 4, 2009 The incidence of pneumothorax (PTX), or ... trauma has been reported to range from 13 50 ... In people, PTX is reported to be the most ... Thoracic ultrasound has been infrequently used as a non-invasive, point-of-care ...
... not lower, costs and very large reductions in greenhouse ... the key take-home messages from a series of expert ... Future (RBAEF)" in a special issue of Biofuels, ... that the collection, which includes a comparative analysis of ...
... March 3, 2009 "Undesirable" evolution in fish ... dwindle -- can actually be reversed in a few ... fishing, according to groundbreaking new research published today by ... Royal Society B . Intensive harvesting of the ...
Cached Biology News:Novel veterinary procedure detecting life-threatening injuries touted 2Cellulosic biofuel technology will generate low-cost green fuel, says major study 2Cellulosic biofuel technology will generate low-cost green fuel, says major study 3'Undesirable' evolution can be reversed in fish, Stony Brook University scientists show 2'Undesirable' evolution can be reversed in fish, Stony Brook University scientists show 3
(Date:8/3/2015)...  MiMedx Group, Inc. (NASDAQ: MDXG ), the ... patent-protected processes to develop and market advanced products and ... Medicine, Ophthalmic and Dental sectors of healthcare, announced today ... Annual Canaccord|Genuity Growth Conference in Boston, Massachusetts ... William C. Taylor , President and COO, and ...
(Date:8/3/2015)...  Merck KGaA, Darmstadt, Germany , ... in the healthcare, life science and performance materials sectors, ... development and launch of promising new fullerene derivatives for ... Darmstadt, Germany , is pursuing many ... Novel derivatives: highly stable, easy to process and ...
(Date:8/3/2015)... , Aug. 3, 2015  Aethlon Medical, Inc. (Nasdaq: ... to treat life-threatening diseases, today announced that it will ... and webcast on Thursday, August 13, 2015 at 4:30 ... will follow the release of fiscal 2016 first quarter ... available approximately two hours after the call at the ...
(Date:8/3/2015)... Md. , Aug. 3, 2015   Intrexon ... will release first half and second quarter 2015 financial ... th , 2015.  The Company will host a conference ... and provide a general business update. The ... US) and 1-412-902-4262 (International), and asking to join the ...
Breaking Biology Technology:MiMedx To Present At 35th Annual Canaccord|Genuity Growth Conference 2Merck KGaA, Darmstadt, Germany, and Nano-C Present Enhanced Materials for Organic Photovoltaics 2Merck KGaA, Darmstadt, Germany, and Nano-C Present Enhanced Materials for Organic Photovoltaics 3Merck KGaA, Darmstadt, Germany, and Nano-C Present Enhanced Materials for Organic Photovoltaics 4Aethlon Medical To Host First Quarter Fiscal 2016 Investor Call on August 13, 2015 2Intrexon to Announce First Half and Second Quarter 2015 Financial Results and Host Conference Call on August 10th 2
... Therapeutics Inc.,(Lorus), a biopharmaceutical company specializing in the research ... cancer, today reported financial results for the three and ... amounts are in Canadian,dollars., 2008 HIGHLIGHTS, ... Lorus, lead anticancer small ...
... N.J., July 21 Schering-Plough,Corporation (NYSE: SGP ... call and,webcast to review the sales and earnings ... p.m. (EDT) from 8 a.m. today. The quarterly,financial ... after the close of,the New York Stock Exchange., ...
... Limited (TSX: GEN),a company focused on developing ... diseases and personalized health management, today announced,the ... molecular test,for colorectal cancer screening. ColonSentry(TM) is ... risk of having colorectal cancer, identifying,those in ...
Cached Biology Technology:Lorus Therapeutics Reports Fourth Quarter Results for Fiscal Year 2008 2Lorus Therapeutics Reports Fourth Quarter Results for Fiscal Year 2008 3Lorus Therapeutics Reports Fourth Quarter Results for Fiscal Year 2008 4Lorus Therapeutics Reports Fourth Quarter Results for Fiscal Year 2008 5Lorus Therapeutics Reports Fourth Quarter Results for Fiscal Year 2008 6Lorus Therapeutics Reports Fourth Quarter Results for Fiscal Year 2008 7Lorus Therapeutics Reports Fourth Quarter Results for Fiscal Year 2008 8Schering-Plough Reschedules Time of Conference Call, Webcast for 2008 Second Quarter Earnings to Later Today 2GeneNews launches world's first blood test for colorectal cancer screening 2GeneNews launches world's first blood test for colorectal cancer screening 3
Each Yeast-GFP clone represents an individual S. cerevisiae strain containing an open reading frame with a C-terminal Aequorea Victoria GFP (S65T) fusion tag....
... has joined forces with the Mickle Laboratory ... Tissue Chopper. This tissue sectioning system has ... for metabolic experiments and to be especially ... at biopsy or from small organs. Its ...
Without sodium bicarbonate. Sterile, Cell culture tested...
... are molecules of peptidic nature or origin ... which can be developed at the industrial ... applications. In this way it is possible ... for therapeutic applications. Primm offers a design ...
Biology Products: